| Literature DB >> 31457065 |
Cliodhna McHugh1, Karen Hind2, Daniel Davey3, Fiona Wilson1.
Abstract
BACKGROUND: Retirement from elite sport participation is associated with decreased physical activity, depression, obesity, and ischemic heart disease. Although engagement in physical activity through sport is recognized as cardioprotective, an estimated one-quarter of deaths in American football players are associated with cardiovascular disease (CVD), predominately in players classified as obese.Entities:
Keywords: cardiovascular; evidence-based review; field-based; heart disease; retired athletes; risk factors
Year: 2019 PMID: 31457065 PMCID: PMC6700959 DOI: 10.1177/2325967119862750
Source DB: PubMed Journal: Orthop J Sports Med ISSN: 2325-9671
Figure 1.PRISMA (Preferred Reporting Items for Systematic Meta-Analyses) flow diagram. BMI, body mass index; CVD, cardiovascular disease; ECG, electrocardiogram; ECHO, echocardiography; GAA, Gaelic Athletic Association; NFL, National Football League.
Study Details
| Author (Year) | Study Design | Primary Aims | Setting | Participants | Variables | Risk Factor Prevalence |
|---|---|---|---|---|---|---|
| Miller et al[ | Cross-sectional prevalence | To assess the prevalence of CMS in athletes; to assess the prevalence of CMS based on playing position | Living Heart Foundation health screening, 2004-2006 | NFL; n = 510; male; mean age: 53.8 y; sex-matched controls from NHANES; LM vs NLM | BMI, BF%, SBP, DBP, HT, TC, TG, HDL, LDL, fasting glucose, CMS, smoking, DM | CMS was more prevalent in LM than NLM (59.8% vs 30.1%, respectively; |
| Panayiotoglou et al[ | Cross-sectional case-control | To determine the risk and prevalence of CMS in retired professional soccer players | Greece | Soccer; n = 12; male; mean age: 46.7 y; age-, sex-, and BMI-matched nonathletic controls | BMI, BF%, WHR, blood pressure, snoring, smoking, TG, TC/HDL, non-HDL/HDL | Prevalence of CMS was not different between groups; retired players with CMS gained significantly more weight since retirement |
| Basra et al[ | Cross-sectional | To evaluate the presence and severity of subclinical atherosclerosis; to evaluate whether the lineman position is independently associated with an increased risk of subclinical atherosclerosis | Living Heart Foundation health screening, 2007-2009 | NFL; n = 931; male; mean age: 54 y; no comparators; LM vs NLM | BMI, WC, SBP, hs-CRP, TC, HDL-C, LDL-C, TG, fasting glucose, CMS, HT, DM, smoking, CAC | LM were less likely to have absence of CAC (33.8% vs 41.7%, respectively; |
| Chang et al[ | Cross-sectional | To assess the prevalence of CAC in retired NFL players compared with physically active controls; to evaluate retired players’ true risk of an adverse cardiovascular event | Living Heart Foundation health screening, 2007 | NFL; n = 201; male; mean age: 51.2 y; age-, sex-, BMI-, and ethnicity-matched participants from DHS and ACLS | BMI, WC, WHR, SBP, DBP, fasting insulin, fasting glucose, TC, HDL, LDL, TG, HbA1C, CMS, DM, smoking, CAC, HT, hs-CRP | There was no significant difference in CAC prevalence (46.0% vs 48.3%, respectively; |
| Hurst et al[ | Cross-sectional | To evaluate subclinical atherosclerosis in retired NFL players; to assess the cardiovascular risk in professional football players | Living Heart Foundation health screening, 2006-2007 | NFL; n = 201; male; mean age: 50.8 y; age-, sex-, BMI-, and smoking prevalence–matched controls from Mayo (2006-2007); LM vs NLM | BMI, smoking, HT, SBP, DBP, hyperlipidemia, TC, HDL, LDL, TG, TC/HDL, fasting glucose, CAP, CMS | Prevalence of CAP in players was not significantly different to BMI-matched controls (33.3% vs 29.3%, respectively; |
| Hyman et al[ | Observational | To validate the accuracy of BMI when measuring obesity in the retired NFL population; to investigate the correlation between obesity and several comorbidities in this population | Internal medicine practice, 5/2010-6/2011 | NFL; n = 129; male; mean age: 42.2 y; no comparators; LM vs NLM | BMI, HT, obstructive SA, left ventricular hypertrophy, DM | BMI has poor specificity (0.36) in classifying obesity in retired football players; BMI/obesity was correlated with LM ( |
| Albuquerque et al[ | Cross-sectional | To assess the prevalence of SDB and HT; to compare the risk of CVD between retired NFL players and controls | Living Heart Foundation health screening, 2006 | NFL; n = 257; male; mean age: 53.9 y; age-, sex-, and BMI-matched cohort from NHANES | BMI, SBP, DBP, HT, obesity, TC, TG, HDL, LDL, fasting glucose, DM, smoking, apnea-hypopnea, SDB | SDB was present in 52.3% of retired players; prevalence of HT and obesity ( |
| Carruthers et al[ | Cross-sectional | To assess the 10-y risk of atherosclerotic CVD in elite former athletes | Not specified | NFL; n = 104; male; mean age: 53.8 y; age- and sex-matched participants from DHS | BMI, SBP, non-HDL, HDL, median CAC, median atherosclerotic CVD risk, smoking | Compared with DHS, retired NFL players had no significant differences in odds of having CAC = 0 among participants with a high atherosclerotic CVD risk (OR, 1.37 [95% CI, 0.36-5.17]) or in odds of having high CAC (>100) among participants with a low atherosclerotic CVD risk (OR, 1.28 [95% CI, 0.64-2.54]) |
| Kelly et al[ | Prospective | To determine the rate of metabolic dysfunction in retired NFL players | Providence St John’s Health Center; Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center | NFL; n = 74; male; mean age: 47.3 y; no comparators; non–hormone deficient vs hormone deficient | BMI, CMS, IGF-1 | CMS was present in 50% of retired players; BMI increased significantly ( |
| Lynch et al[ | Cross-sectional | To determine if playing professional football as a young adult is associated with a more favorable cardiovascular risk profile and greater bone density and lean mass compared with their healthy peers | University of Maryland | NFL; n = 16; male; mean age: 66 y; sex-, BMI-, race-, and current physical activity–matched never-athletic comparators | BMI, WC, WHR, BF%, TC, LDL, HDL, TG, fasting insulin, fasting glucose, blood pressure | Retired players had a more favorable body composition and cardiovascular risk profile than controls: 37% higher HDL, 4-fold higher HDL2, 25% lower TC/HDL, and 31% lower TG ( |
| Pokharel et al[ | Cross-sectional | To examine the association of NC with other markers of adiposity and components of CMS; to examine whether NC is independently associated with subclinical atherosclerosis as assessed by CAC and CAP | NFL Player Care Foundation; Living Heart Foundation; Boone Heart Institute | NFL; n = 845; male; mean age: 54 y; no comparators | HT, DM, SBP, DBP, BMI, NC, WC, fasting blood glucose, hs-CRP, TC, LDL, HDL, TG, CMS, CAC/CAP | 21% had CMS, 62% had CAC, and 56% had CAP present; NC was not associated with CAC or CAP after adjusting for age, race, and cardiometabolic risk factors |
| Virani et al[ | Cross-sectional | To assess whether LDL-P concentration and hs-CRP can identify subclinical atherosclerosis better than traditional cholesterol parameters; to assess if hs-CRP is associated with CAP in retired NFL players | Living Heart Foundation and Boone Heart Institute, 9/2007-11/2009 | NFL; n = 948; male; mean age: 53.5 y; no comparators; CMS vs no CMS | HT, DM,CMS, WC, TC, LDL, non-HDL, TG, LDL-P, HDL, hs-CRP | CAP was common in retired players (41%) and strongly associated with LDL-P (OR, 3.71 [95% CI, 1.16-11.84]); 19.7% of retired players had CMS; hs-CRP was not associated with CAP (OR, 1.13 [95% CI, 0.71-1.79]) |
| Luyster et al[ | Cross-sectional | To compare the SA risk in young- to middle-aged retired NFL players with a community cohort; to compare the SA risk based on playing position | NFL Player Care Foundation Cardiovascular Health Screening Program, 2007-2012 | NFL; n = 122; male; mean age: 45.3 y; age-, sex-, race-, and BMI-matched cohort from CARDIA | Smoking, WC, BMI, obesity, SBP, DBP, TC, HDL, LDL, TG, DM, fasting glucose, sleep duration, SA risk, CAC | Retired players had greater prevalence of high SA risk (27.0% vs 11.5%, respectively; |
ACLS, Aerobics Center Longitudinal Study; BF%, body fat percentage; BMI, body mass index; CAC, coronary artery calcium; CAP, carotid artery plaque; CARDIA, Coronary Artery Risk Development in Young Adults; CMS, cardiometabolic syndrome; CVD, cardiovascular disease; DBP, diastolic blood pressure; DHS, Dallas Heart Study; DM, diabetes mellitus; HDL, high-density lipoprotein; HDL-C, high-density lipoprotein cholesterol; hs-CRP, high-sensitivity C-reactive protein; HT, hypertension; IGF-1, insulin-like growth factor 1; LDL, low-density lipoprotein; LDL-C, low-density lipoprotein cholesterol; LDL-P, low-density lipoprotein particle number; LM, linemen; Mayo, Mayo Clinic; NC, neck circumference; NFL, National Football League; NHANES, National Health and Nutrition Examination Survey; NLM, nonlinemen; OR, odds ratio; SA, sleep apnea; SBP, systolic blood pressure; SDB, sleep-disordered breathing; TC, total cholesterol; TG, triglyceride; WC, waist circumference; WHR, waist-to-hip ratio.
Critical Appraisal of Included Studies
| Miller et al[ | Panayiotoglou et al[ | Basra et al[ | Chang et al[ | Hurst et al[ | Hyman et al[ | Albuquerque et al[ | Carruthers et al[ | Kelly et al[ | Lynch et al[ | Pokharel et al[ | Virani et al[ | Luyster et al[ | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| |||||||||||||
| Were the aims/objectives of the study clear? | N | Y | Y | Y | U | Y | N | N | Y | N | Y | Y | Y |
|
| |||||||||||||
| Was the study design appropriate for the stated aim(s)? | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y |
| Was the sample size justified? | N | N | Y | Y | N | N | Y | N | N | N | N | N | Y |
| Was the target reference population clearly defined? | Y | Y | Y | Y | Y | N | Y | Y | Y | Y | Y | Y | Y |
| Was the sample taken from an appropriate population base so that it closely represented the target/reference population under investigation? | Y | Y | Y | Y | Y | N | Y | U | Y | Y | Y | Y | Y |
| Was the selection process likely to select participants who were representative of the target/reference population under investigation? | Y | Y | Y | Y | Y | Y | U | U | Y | Y | Y | Y | Y |
| Were there measures undertaken to address and categorize nonresponders? | N | N | N | N | N | N | U | N | Y | N | U | U | N |
| Were the risk factor and outcome variables measured appropriately to the aims of the study? | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y |
| Were the risk factor and outcome variables measured correctly using instruments/measurements that had been trialed, piloted, or published previously? | Y | Y | Y | Y | Y | U | Y | U | Y | Y | Y | Y | Y |
| Is it clear what was used to determine statistical significance and/or precision estimates (eg, values, CIs)? | Y | Y | Y | Y | Y | N | N | N | Y | Y | Y | Y | Y |
| Were the methods (including statistical methods) sufficiently described to enable them to be repeated? | Y | Y | Y | Y | Y | N | N | N | Y | Y | Y | Y | Y |
|
| |||||||||||||
| Were the basic data adequately described? | Y | Y | Y | Y | Y | Y | N | Y | Y | Y | Y | Y | Y |
| Does the response rate raise concern about nonresponse bias? | Y | Y | N | N | Y | Y | Y | U | N | Y | Y | N | N |
| If appropriate, was information about nonresponders described? | N | N | N | U | U | N | N | U | U | N | U | U | N |
| Were the results internally consistent? | Y | Y | Y | Y | Y | Y | U | Y | Y | Y | Y | Y | Y |
| Were the results for the analyses described in the methods presented? | Y | Y | Y | Y | Y | Y | N | Y | Y | Y | Y | Y | Y |
|
| |||||||||||||
| Were the authors’ discussions and conclusions justified by the results? | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y |
| Were the limitations of the study discussed? | Y | Y | Y | Y | Y | Y | N | Y | Y | Y | Y | Y | Y |
|
| |||||||||||||
| Were there any funding sources or conflicts of interest that may affect the authors’ interpretation of the results? | N | Y | N | N | N | N | N | N | N | N | N | N | N |
| Was ethical approval or consent of participants attained? | Y | Y | Y | Y | Y | Y | U | Y | Y | Y | Y | Y | Y |
Colored text indicates the following: green, positive impact on quality of study; red, negative impact on quality of study; orange, unknown impact on quality of study. N, no; U, unsure; Y, yes.
Body Composition Measures
| Author (Year) | BMI, kg/m2 | WC/NC, cm | BF% | WHR |
|---|---|---|---|---|
| Miller et al[ | LM vs NLM: 34.9 (4.9) vs 30.7 (4.0) | LM vs NLM: 31.4% vs 27.4% | ||
| Panayiotoglou et al[ | Soccer vs control: 27.3 ± 2.8 vs 27.4 ± 2.7, NS | Soccer vs control: 24.5 ± 4.5 vs 27.0 ± 3.9, NS | Soccer vs control: 0.96 ± 0.05 vs 0.97 ± 0.01, NS | |
| Basra et al[ | LM vs NLM: 33.6 (30.5-37.9) vs 30.3 (27.7-33.0) | LM vs NLM: 109.2 (99.1-119.4) vs 99.1 (91.4-106.6) | ||
| Chang et al[ | NFL vs DHS: 31.5 ± 4.2 vs 31.4 ± 4.0, NS | NFL vs DHS: 103.8 ± 11.5 vs 107.4 ± 10.9, NS | NFL vs DHS: 1.08 ± 0.85 vs 0.98 ± 0.05 | |
| Hurst et al[ | NFL vs Mayo: 31.5 ± 4.5 vs 31.0 ± 2.7, NS | |||
| Hyman et al[ | BMI ≥30 = 89 (67%) | BF% ≥25% = 13 (10%) | ||
| Albuquerque et al[ | NFL vs control: 32.3 ± 0.3 vs 30.0 ± 0.1 | |||
| Carruthers et al[ | NFL vs DHS: 32.5 (5.4) vs 29.3 (5.4) | |||
| Kelly et al[ | 33.8 ± 6 | |||
| Lynch et al[ | NFL vs control: 29.4 ± 2.8 vs 30 ± 3, NS | NFL vs control: 101.2 ± 6.8 vs 106.1 ± 8.0, NS | NFL vs control: 23 ± 4 vs 32 ± 7 | NFL vs control: 0.95 ± 0.05 vs 0.98 ± 0.06, NS |
| Pokharel et al[ | 31 (29-35) | WC: 40 (37-44) | ||
| Virani et al[ | WC: 39.4 ± 10.6 | |||
| Luyster et al[ | NFL vs CARDIA: 30.3 ± 3.8 vs 29.9 ± 4.0, NS | NFL vs CARDIA: 95.2 ± 22.0 vs 98.1 ± 10.2, NS |
Data are reported as mean ± SD, median (interquartile range), or n (%). ACLS, Aerobics Center Longitudinal Study; BF%, body fat percentage; BMI, body mass index; CARDIA, Coronary Artery Risk Development in Young Adults; DHS, Dallas Heart Study; LM, linemen; Mayo, Mayo Clinic; NC, neck circumference; NFL, National Football League; NLM, nonlinemen; NS, not significant; WC, waist circumference; WHR, waist-to-hip ratio.
< .001.
Risk Factors for Cardiovascular Disease
| Author (Year) | Blood Pressure | Lipids, mg/dL | CAC | CMS |
|---|---|---|---|---|
| Miller et al[ | LM vs NLM: | LM vs NLM: | LM vs NLM: 98 (59.8%) vs 104 (30.1%) | |
| Panayiotoglou et al[ | Soccer vs control: | |||
| Basra et al[ | LM vs NLM: | LM vs NLM: | LM vs NLM: | LM vs NLM: 25.8% vs 16.5% |
| Chang et al[ | NFL vs DHS: | NFL vs DHS: | NFL vs DHS: 46.0% vs 48.3%, NS | NFL vs DHS: significantly lower percentage of retired players with CMS compared with controls |
| Hurst et al[ | NFL vs Mayo: | NFL vs Mayo: | NFL vs Mayo: CAP: 67 (33%) vs 36 (29%), NS | LM vs NLM: 27 (46%) vs 32 (23%) |
| Hyman et al[ | HT: 55 (42.6%) | |||
| Albuquerque et al[ | NFL vs control: | NFL vs control: | ||
| Carruthers et al[ | NFL vs DHS: | NFL vs DHS: | NFL vs DHS: | |
| Kelly et al[ | 34 (50%) | |||
| Lynch et al[ | NFL vs control: | NFL vs control: | ||
| Pokharel et al[ | HT: 267 (32%) | HDL: 47 (39-56) | ||
| Virani et al[ | HT: 309 (34.7%) | HDL: 49 ± 14 | CAP detected in 41% of players | 187 (19.7%) |
| Luyster et al[ | NFL vs CARDIA: | NFL vs CARDIA: | NFL vs CARDIA: |
Data are reported as mean ± SD, median (interquartile range), or n (%). ACLS, Aerobics Center Longitudinal Study; BMI, body mass index; CAC, coronary artery calcium; CAP, carotid artery plaque; CARDIA, Coronary Artery Risk Development in Young Adults; CMS, cardiometabolic syndrome; DBP, diastolic blood pressure; DHS, Dallas Heart Study; HDL, high-density lipoprotein; HT, hypertension; LDL, low-density lipoprotein; LM, linemen; Mayo, Mayo Clinic; NFL, National Football League; NLM, nonlinemen; NS, not significant; SBP, systolic blood pressure; TC, total cholesterol; TG, triglyceride.
< .01.
< .05.
< .001.
Figure 2.Forest plot of systolic blood pressure. IV, instrumental variable.
Figure 3.Forest plot of glucose. IV, instrumental variable.
Figure 4.Forest plot of triglyceride. IV, instrumental variable.
Figure 5.Forest plot of low-density lipoprotein (LDL). IV, instrumental variable.